Mian S - Search Results

1

Phenotypic and functional differences of dendritic cells generated under different in vitro conditions.

McArdle SE, Ali SA, Li G, Mian S, Rees RC. McArdle SE, et al. Among authors: mian s. Methods Mol Med. 2003;81:359-75. doi: 10.1385/1-59259-372-0:359. Methods Mol Med. 2003. PMID: 12725131 No abstract available.

2

Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancer.

Rees RC, McArdle S, Mian S, Li G, Ahmad M, Parkinson R, Ali SA. Rees RC, et al. Among authors: mian s. Curr Opin Mol Ther. 2002 Feb;4(1):49-53. Curr Opin Mol Ther. 2002. PMID: 11883695 Review.

3

Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunity.

Ali SA, Lynam J, McLean CS, Entwisle C, Loudon P, Rojas JM, McArdle SE, Li G, Mian S, Rees RC. Ali SA, et al. Among authors: mian s. J Immunol. 2002 Apr 1;168(7):3512-9. doi: 10.4049/jimmunol.168.7.3512. J Immunol. 2002. PMID: 11907113

4

Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancer therapy.

Parkinson RJ, Mian S, Bishop MC, Gray T, Li G, McArdle SE, Ali S, Rees RC. Parkinson RJ, et al. Among authors: mian s. Prostate. 2003 Jun 15;56(1):65-73. doi: 10.1002/pros.10207. Prostate. 2003. PMID: 12746848

5

A prototype methodology combining surface-enhanced laser desorption/ionization protein chip technology and artificial neural network algorithms to predict the chemoresponsiveness of breast cancer cell lines exposed to Paclitaxel and Doxorubicin under in vitro conditions.

Mian S, Ball G, Hornbuckle J, Holding F, Carmichael J, Ellis I, Ali S, Li G, McArdle S, Creaser C, Rees R. Mian S, et al. Proteomics. 2003 Sep;3(9):1725-37. doi: 10.1002/pmic.200300526. Proteomics. 2003. PMID: 12973733

6

Anti-tumour therapeutic efficacy of OX40L in murine tumour model.

Ali SA, Ahmad M, Lynam J, McLean CS, Entwisle C, Loudon P, Choolun E, McArdle SE, Li G, Mian S, Rees RC. Ali SA, et al. Among authors: mian s. Vaccine. 2004 Sep 9;22(27-28):3585-94. doi: 10.1016/j.vaccine.2004.03.041. Vaccine. 2004. PMID: 15315837 Free article.

7

Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53.

Rojas JM, McArdle SE, Horton RB, Bell M, Mian S, Li G, Ali SA, Rees RC. Rojas JM, et al. Among authors: mian s. Cancer Immunol Immunother. 2005 Mar;54(3):243-53. doi: 10.1007/s00262-004-0596-7. Epub 2004 Sep 21. Cancer Immunol Immunother. 2005. PMID: 15449037 Free PMC article.

8

Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4+ T cells in mice failing immunotherapy with DISC-mGM-CSF.

Ahmad M, Rees RC, McArdle SE, Li G, Mian S, Entwisle C, Loudon P, Ali SA. Ahmad M, et al. Among authors: mian s. Int J Cancer. 2005 Jul 20;115(6):951-9. doi: 10.1002/ijc.20976. Int J Cancer. 2005. PMID: 15723299

9

Immunity to tumour antigens.

Li G, Ali SA, McArdle SE, Mian S, Ahmad M, Miles A, Rees RC. Li G, et al. Among authors: mian s. Curr Pharm Des. 2005;11(27):3501-9. doi: 10.2174/138161205774414583. Curr Pharm Des. 2005. PMID: 16248804 Review.

10

Selective MHC expression in tumours modulates adaptive and innate antitumour responses.

Rees RC, Mian S. Rees RC, et al. Among authors: mian s. Cancer Immunol Immunother. 1999 Oct;48(7):374-81. doi: 10.1007/s002620050589. Cancer Immunol Immunother. 1999. PMID: 10501850 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters